Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
5(29%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_4
2
12%
Ph phase_1
2
12%
Ph phase_2
5
29%
Ph phase_3
1
6%
Ph not_applicable
5
29%
Ph early_phase_1
1
6%

Phase Distribution

3

Early Stage

5

Mid Stage

3

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 1Safety & dosage
2(12.5%)
Phase 2Efficacy & side effects
5(31.3%)
Phase 3Large-scale testing
1(6.3%)
Phase 4Post-market surveillance
2(12.5%)
N/ANon-phased studies
5(31.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

17

all time

Status Distribution
Active(6)
Completed(9)
Other(2)

Detailed Status

Completed9
Recruiting3
Active, not recruiting2
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
5
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.3%)
Phase 12 (12.5%)
Phase 25 (31.3%)
Phase 31 (6.3%)
Phase 42 (12.5%)
N/A5 (31.3%)

Trials by Status

active_not_recruiting212%
completed953%
not_yet_recruiting16%
recruiting318%
unknown212%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT04512287Phase 2

PRP for Treatment of Peyronie's Disease

Completed
NCT07117955Not Applicable

Platelet-Rich Plasma for Peyronie's Disease

Recruiting
NCT06789510Not Applicable

Treatment of Peyronie's Disease With Platelet-Rich Plasma

Active Not Recruiting
NCT07005661Phase 2

Use of PRP in Open Surgery for Type A Aortic Dissection

Not Yet Recruiting
NCT04381299

Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function?

Active Not Recruiting
NCT05181748Phase 2

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Recruiting
NCT04031456Phase 2

Autologous PRP Infusion May Restore Ovarian Function and May Promote Folliculogenesis in POI Patients

Recruiting
NCT04396795Phase 2

Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction.

Completed
NCT04350125Phase 1

PRP for the Treatment of Erectile Dysfunction (ED)

Completed
NCT04522674Early Phase 1

Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine

Completed
NCT02591355Not Applicable

Evaluate the Clinical Effectiveness of RegenKit Platelet-rich Plasma (PRP) in Androgenetic Alopecia Treatment

Completed
NCT01911650Not Applicable

A Pilot Study: Treatment of Achilles Tendinopathy With Platelet-Rich Plasma Therapy

Completed
NCT03779945Phase 4

Effect of Platelet-Rich-Plasma in Spine Fusion

Unknown
NCT03261843Phase 4

The Effect of Using Autologous Platelet Rich Plasma on Posterior Lumbar Interbody Fusion

Unknown
NCT02828163Phase 3

Comparison Between Injections of Steroids and Autologous Platelet Rich Plasma in the Oral Erosions of Pemphigus Vulgaris

Completed
NCT02794363Not Applicable

Platelet Rich Plasma Injections for Vulvar Lichen Sclerosus

Completed
NCT00856934Phase 1

Effect of Platelet Rich Plasma and Keratinocyte Suspensions on Wound Healing

Completed

All 17 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
17